animal model comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-05-14. Numbers and descriptions here follow the published literature rather than marketing material.
Most published work on BPC-157 consists of preclinical studies, including rodent models of tissue injury, gastrointestinal lesions, and vascular or tendon damage, together with in vitro cell assays. Reviews frequently note that the mechanisms proposed in these papers remain incompletely characterised and that findings have not been confirmed in large randomised human trials. The compound is widely sold as a research chemical rather than a licensed medicine, and labels commonly carry a statement that it is not for human use. Whether any of the reported animal effects translate to humans is an open question rather than an established result.
Terminology in the literature is not fully standardised. Papers and product listings use BPC-157, BPC 157, and the longer phrase stable gastric pentadecapeptide BPC 157 interchangeably, and synonyms such as bepecin or PL 14736 appear in older or company-linked publications. Purity claims and reported masses can also differ between sources because peptide preparations may include counterions, residual solvents, or bound water. This variability complicates direct comparison of results across studies and makes the exact identity and grade of a given sample worth verifying. Discussions of the compound should therefore specify the source, salt form, and stated purity where those are known.
Published studies on BPC-157 are dominated by animal models. Commonly used endpoints include healing of surgically induced lesions in the stomach, tendon-to-bone attachment after transection, and recovery from experimentally induced vascular or intestinal damage. Many of these reports come from a small number of research groups, and the peptide is often described as acting across a wide range of tissue types. That breadth is itself a point of discussion, since one molecule influencing many unrelated systems is unusual.
Human data are far more limited than animal data. A small number of clinical reports exist, generally with few participants and without the randomization or blinding expected in later-phase trials. No large, independently replicated human trial has appeared in the indexed peer-reviewed literature. Statements about effects in people therefore rest on extrapolation from animal work rather than on direct evidence, and the strength of that extrapolation remains an open question rather than a settled matter.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C62H98N16O22 | Computed for the free peptide |
| Monoisotopic mass | Approximately 1419 Da | Reported values shift with counterion and hydration |
| Residue count | 15 amino acids | Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| Origin | Fragment of human gastric juice protein | First described in early 1990s research reports |
| Common synonyms | BPC 157; PL 14736; bepecin | Naming varies across papers and catalogues |
Lyophilized material is generally kept cold, commonly at minus twenty degrees Celsius, and shielded from moisture and light. Solutions are less stable than the dry powder, so repeated freeze-thaw cycles are avoided by splitting the material into single-use portions. Published stability data for this particular peptide are limited, which means suggested hold times should be read as provisional. Long-term refrigeration of reconstituted solutions is not well supported by available evidence.
Identity and purity are checked with standard peptide techniques. Reversed-phase high-performance liquid chromatography separates the main peak from closely related impurities and yields a percentage purity. Mass spectrometry confirms that the measured mass matches the theoretical value. Amino acid analysis offers an independent check on overall composition. These analytical methods characterize the material itself and reveal nothing about how it behaves in a living system.
In its common research form the peptide is supplied as a lyophilized powder. It dissolves readily in water and in typical aqueous buffers, which simplifies preparation of working solutions. Laboratories usually prepare small aliquots instead of one large volume. The dry material appears as a white to off-white solid with no distinctive odor. Bulk quantities are typically shipped in sealed vials.
Several mechanisms have been proposed to explain the activity observed in animal models. The most frequently cited involve signaling through vascular endothelial growth factor receptor 2 and modulation of the nitric oxide system. Researchers have also described interactions with protective pathways in the gut lining. These proposed mechanisms appear in the literature as hypotheses supported by preclinical observations, not as confirmed pathways in humans. The precise way the peptide produces its reported effects, and whether those effects carry across species, remain areas of active and unresolved investigation.
BPC-157 is a synthetic pentadecapeptide, meaning it consists of fifteen amino acids joined in a single chain. Its sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, a fragment corresponding to part of a larger protein found in human gastric juice. The peptide was first described in the 1990s by researchers in Zagreb who were studying gastric protective factors. It is not a naturally circulating hormone; it is a laboratory-made fragment derived from a stomach protein. The name is an abbreviation of body protection compound, with the number referring to the fragment's position in the source protein.
Most published work on BPC-157 comes from animal experiments rather than controlled human trials. Rodent models have examined its effects on gastrointestinal lesions, tendon and ligament injury, and blood vessel formation. These studies are often small and originate from a limited number of research groups, which affects how broadly the findings can be generalized. No large randomized human trial has been reported in the peer-reviewed literature. Discussion of the compound therefore rests largely on preclinical data, and questions about its effects in people remain open rather than settled.
Lyophilized material is generally reported as stable for extended periods when kept cold, dry, and protected from light. In solution, the main degradation routes for a peptide of this type are hydrolysis of peptide bonds and aggregation. The sequence contains no cysteine, so disulfide-driven oxidation is not a primary concern, though methionine and tryptophan are also absent. Stability depends on pH, buffer composition, and concentration, with acidic conditions often reported as more favorable than neutral or alkaline ones. Repeated freeze-thaw cycles can promote aggregation, and how fast degradation proceeds at room temperature in specific formulations remains an open question.
Handling practice centers on limiting moisture, heat, and mechanical stress. Powder is typically allowed to reach room temperature before opening so that condensation does not form on the contents, and solutions are prepared with sterile or low-particulate water. Peptides can adsorb to certain plastics and membrane filters, so container and filter material is sometimes specified to reduce losses at low concentrations. Working aliquots are usually frozen separately rather than sampled repeatedly from one stock. Recording lot number, preparation date, and storage conditions supports later comparison between experiments.
Cervarix, GARDASIL and GARDASIL9 are three recombinant subunit vaccines licensed for the protection against HPV infection. They differ in the strains which they protect the patients from as Cervarix confers protection against type 16 and 18, Gardasil confers protection against type 6, 11, 16 and 18, and Gardasil 9 confers protection against type 6, 11, 16, 18, 31, 33, 45, 52, 58 respectively. The vaccines contain purified VLP of the major capsid L1 protein produced by recombinant Saccharomyces cerevisiae. It has been shown in a 2014 systematic quantitative review that the bivalent HPV vaccine (Cervarix) is associated with pain (OR 3.29; 95% CI: 3.00–3.60), swelling (OR 3.14; 95% CI: 2.79–3.53) and redness (OR 2.41; 95% CI: 2.17–2.68) being the most frequently reported adverse effects. For Gardasil, the most frequently reported events were pain (OR 2.88; 95% CI: 2.42–3.43) and swelling (OR 2.65; 95% CI: 2.0–3.44). Gardasil was discontinued in the U.S. on May 8, 2017, after the introduction of Gardasil 9 and Cervarix was also voluntarily withdrawn in the U.S. on August 8, 2016.
=== Metabolic and covalent labeling of glycans === Metabolic labeling of glycans can be used as a way to detect glycan structures. A well known strategy involves the use of azide-labeled sugars which can be reacted using the Staudinger ligation. This method has been used for in vitro and in vivo imaging of glycans.
=== 1988 === 11 February Running to Time, about the new InterCity 225; the National Express Coaches Rapide service; the project team of the Intercity 225, with project director Mike Rollin, and Mike Newman of GEC; the 225 train had to be delivered on 14 February 1988, with an operational life of thirty years; the InterCity 125 was not intended to have been primarily developed - in a board meeting, the commercial directors were not technologically knowledgeable of trains, and asked about alternatives, to be told by an engineering director that a 125 mph diesel train could be developed in two years, so the HST began at that meeting; the British Rail APT-E prototype, powered by the Leyland 2S/350 gas turbine; in 1974 BR commissioned the APT-P, which had ten years of development, due to the active tilting suspension; the 225 train was possibly to enter service on the UK's only large electrified line, the West Coast Main Line, but the much-straighter and faster East Coast Main Line was being electrified, so BR decided to implement the 225 train on the ECML instead; Crewe railway station, which opened in 1837, and where trains were first built nearby in 1843; Steve Corfield, of Crewe Works; the unsprung mass of a train, and Cardan shafts; Roger Ford of Modern Railways; John Prideaux, director of InterCity; David Carter of DCA in Warwick, who designed the livery; the Modernisation Plan was published in December 1954, which had advocated the electrification of the ECML, and the phasing-out of steam travel; the late-1980s ECML electrification had cost BR £350m - it was not government-funded, with 2,800 miles of copper wire, and 33,000 support masts, overseen by Don Heath; all of the improvements in the UK were on old lines of track, but France and Germany had built entire new electrified lines - the TGV was planned from the mid-1960s; G. Freeman Allen of Jane's World Railways; the 225 train underframe being built at Crewe Works; GEC Traction at Preston, Lancashire, Al Reed, the separately excited (Armature Controlled DC Motor) brushed DC electric motor, and Gerald West; the right-angle gearboxes were built by David Brown Ltd and Voith of Heidenheim an der Brenz in southern Germany; Eric Black of Metro-Cammell in Washwood Heath; the ST41 bogies were made by SIG Combibloc Group of Neuhausen am Rheinfall in Switzerland. Narrated by Robin Ellis, produced by Patrick Uden, directed by Paul Fabricius, made by Uden Associates. 12 February Playing with Fire 17 July The Air Fix!, about aviation safety; a television adaptation of a black comedy theatre production by 35-year-old James Castle, dressed as an airline pilot, largely featuring Turkish Airlines Flight 981, the Ermenonville air disaster, in France on 3 March 1974, to this day the worst airliner crash, without any survivors, with 177 British people killed, when a cargo door ruptured, and the subsequent enquiry led to a cover up by the airline and aviation authority; the DC10 had known design failings in its fuselage, and its cargo door design was known to be faulty by the aircraft manufacturer; the American Airlines Flight 96 crash had happened on 12 June 1972, involving a design failure of the cargo door, but the FAA nonetheless gave the DC-10 a certificate of airworthiness; the DC10 had been rushed into service; James Castle accused the aircraft industry of callous negligence; James Castle had been a British Airways aircraft maintenance technician from 1969 to 1977 at Heathrow Airport; he listed the numbers of children that lost one or both parents in the crash, and the numbers of women who were widowed; the theatre production had been going since December 1986, directed by Caroline Noh Narrated by James Castle, produced by Ben Gooder, made by Uden Associates 24 July Nic's Boat, about Nic Bailey, a 37-year-old architect with Foster and Partners; he designed a 40-ft trimaran, called MTC, for the Carlsberg Single-Handed Trans-Atlantic Race on 5 June 1988; he had helped to design the 1978 Sainsbury Centre for Visual Arts in Norwich and the Renault Centre in Swindon; boat builder Spud Rowsell in Exmouth, with Phil Morrison; the hull cost £46,000, and the rigging cost £46,000; the mast and rigging were fitted at Topsham, Devon; Robin Knox-Johnston; French yacht designer Bruno Fehrenbach; he sailed the Atlantic between the Rhumb Line Route and the Great Circle Route; some yachts made the journey to Newport, Rhode Island in ten days; the yacht mast was constructed by Proctor South West. Produced by Michael Wills, directed by Bob Bee, made by Juniper Productions 31 July The Living Dead 7 August Zen and the Art of TV Manufacture, a Panasonic TV factory in South Wales; in 1933 the company founder Kōnosuke Matsushita established seven guiding commercial principles; the Fidelity TV factory in west London was given one year - 1988 - to turn its fortunes around or be closed; the factory's closure was announced to the workforce on 25 January 1988, with the site closing at the end of July 1988; Amstrad bought the Fidelity name in May 1988. Narrated by Alan Howard, directed by Patrick Uden, produced by Michael Proudfoot, made by Uden Associates 14 August How Good Is Soviet Science?, about the political inhibition of Soviet technology in the 1980s; in many ways the Soviet Union in 1987 was a backward and underdeveloped nation, with food queues; the Soviet system didn't respond to changes in demand - everything was planned years in advance; physicist Alexander Prokhorov, who won the Nobel Prize for Physics in 1964; Russians were proud of mathematicians Pafnuty Chebyshev and Nikolai Lobachevsky; large government centrally planned projects were compatible with the communist system, notably its space programme; by the 1970s, the Russians realised that they were some distance behind other countries, such as in disciplines of computing and genetics; science teaching was emphasised at Soviet schools, and English was well taught as well; after secondary schools, half went into science; theoretical science was where Soviet teaching excelled, such as at the Steklov Institute of Mathematics; Yuri Ovchinnikov wanted to improve Soviet science; in the early 1950s, the Soviet Union tried to ignore the findings of genetics, through the work of Trofim Lysenko, who claimed that genetics was anti-communist, known as Lysenkoism leading to many scientists being imprisoned and executed; in the 1960s, a set of large biological research centres were built at Pushchino; one of the most well-built research institutes was the Shemyakin Institute of Bioorganic Chemistry, for biotechnology; Stalin did not like computer science, and it was largely banned until 1958; the Soviets were always years behind in computer science; the first recognisable transistor Soviet computer was the BESM-6 in the 1960s; later computers were the ES EVM series, copied from the IBM System/360; the Akademgorodok (Academic City) in Novosibirsk; the Institute of Automation and Electrometry researched optical memory on holographic slides to and much work on lasers; collaboration between Soviet research and Soviet industry was long-winded, maybe almost impossible - the centrally planned Soviet industry could not sufficiently adapt for short-term changes, as it had to be monotonously planned years in advance, for mass production; Soviet government research was perhaps excellent nonetheless; not many Soviet scientists could travel to international conferences; dissemination of current worldwide science was limited throughout the Soviet Union, due to widespread government restrictions; Suite No. 2 in B minor, BWV 1067. Narrated by US technology historian Loren Graham, produced by Chris Durlacher, directed by Martin Smith, made by Uden Associates, NDR and WGBH. Shown on Nova on 17 November 1987 and 22 March 1988 21 August Toys for the Boys, about the Williams racing team; Graham Hill and Jim Clark in 1967; Tomorrow's World in 1967, narrated by Derek Cooper; journalist Peter Windsor of Williams; aerodynamicist Frank Dernie, head of research at Williams; Keith Botsford, motor racing editor of the Sunday Times; the German racing manager Alfred Neubauer, in the late 1930s; there were 18 F1 teams, with 7 being British; Mobil Oil paid Williams £2.5m for advertising on the cars of Nigel Mansell and Riccardo Patrese; the Williams FW11; racing driver Howden Ganley; part of a BBC Horizon documentary broadcast on 9 March 1981, featuring the Williams FW07, and likewise narrated by Martin Jarvis and produced by Patrick Uden; engineering director Sir Patrick Head; Bach Mass in B minor; Mike Hawthorn, was killed on a public road, the A3 Guildford bypass, in his Jaguar Mark 1 on 22 January 1959; Canadian Gilles Villeneuve was thrown from his Ferrari, when qualifying for the 1982 Belgian Grand Prix; Swedish Ronnie Peterson, died after an accident on the start line at the 1978 Italian Grand Prix; Italian Elio de Angelis was killed in May 1986 at the Circuit Paul Ricard in south-east France; British Piers Courage burned to death at the 1970 Dutch Grand Prix; Jim Clark hit a tree on 7 April 1968 at the 1968 Deutschland Trophäe in the north-west of Baden-Württemberg; German Jochen Rindt was killed at the 1970 Italian Grand Prix after winning the championship in the same year, which was awarded posthumously; Bach Mass in B minor; Frank Williams had a crash on 8 March 1986 in the south of France, with Peter Windsor, in a Ford Sierra, making him quadraplegic; the Williams wind tunnel; Alan Jones waving the British flag at the 1980 Grand Prix; the 1988 season Williams car had a Judd V8 engine; the closing fanfare of Les préludes by Liszt; the documentary ends with German military march Prussia's Glory. Narrated by Martin Jarvis, produced by Patrick Uden, made by Uden Associates 28 August Cold Spring, Morning Sun, about atomic physicist Joan Hinton and her husband Erwin Engst. Joan's mother was teacher Carmelita Hinton. Joan worked on the top secret Manhattan Project at Los Alamos in 1944 which produced the atomic bombs that were dropped on Hiroshima and Hagasaki in the summer of 1945. After the war, Joan, her brother Bill, and her husband Erwin (Sid) Engst travelled to China to join Mao Ze Dong and the cultural revolution. Over the next five decades, Joan and Sid became pioneers in Chinese agricultural science and technology. Narrated by Liza Goddard, written, produced and directed by Chris Haws, Made by InCA. 18 September Taking the Tunnel, who would be travelling through the Channel Tunnel; the tunnel would open in May 1993; Colin Kirkland, technical director of Eurotunnel; Roger Vickerman of the University of Kent; historian Corelli Barnett, and how France and Germany spent money after the war improving rail infrastructure; journalist Kathy Watson; a working model was built of the two Channel rail terminals; 90% of the tunnel went through chalk; the French end was built much more water-tight than the English end, due to the worse geology; the tunnel was around one mile long at the English end, to meet the French side in 1990; the Single Market would stop duty free sales on the Channel ferries; the former Night Ferry across the Channel, which operated until 30 October 1980; TGV Est would connect Bordeaux, and TGV Nord would connect to Germany, the Netherlands, with a spur to the new tunnel; Richard D. North; tolls on the autoroutes discouraged local traffic, which slowed down British motorways; Daniel Ghouzi of Transmanche; Martin Simmons of Kent County Council; A292 junction of M20; Corelli Barnett believed that the British civil service was best at fudging, whereas the French civil service had been trained differently at the French grandes ecoles; a VTG ship from Dover to Dieppe carried trains; freight journeys over 250 miles were most cost effective by rail, but did lack logistical flexibility at either end; Michael Barclay of Tiphook Rail; a distribution centre in Paddock Wood in Kent, built by the Spanish Transfesa; UIC gauge was the main European gauge for freight; Artura Boix of Transfesa; Richard Hope of Railway Gazette; British trains had a 25 tonne axle weight, more than the European 22 tonnes; early plans for the new Eurostar trains, which would be dual voltage for travelling in England and France; rail writer Geoffrey Freeman Allen; the French trains would leave from the Gard du Nord; customs checks would be at the British end in London, but not in France; British Rail planned a high speed line across Kent to open in 1998 from King's Cross, but it would not open until September 2003, and to London in November 2007; Roger Ford of Modern Railways. Narrated by Geoffrey Palmer, produced by Patrick Uden, directed by Paul Fabricius, made by Uden Associates 25 September Road Test about road transport in the UK; there were two million vehicles in the UK in 1930; a test drive would be conducted from The Point, Milton Keynes at 8.30am to Maidstone, by different routes - Mike McDonald of the University of Southampton and Margaret Bell of the University of Nottingham in a Volvo 850 would go across London, and Peter Bonsall and Howard Kirby of the University of Leeds in a Volkswagen Passat B3, would follow the M25 to the north of London, George Hazel of Napier College and John Wootten in a Ford Granada would follow the M25 south of London, and Martin J. H. Mogridge would take the train on the new Thameslink from Bedford railway station via Blackfriars Railway Bridge; the test would be directed from the Road Traffic Research Centre at Middlesex Polytechnic, with Chris Wright, Peter Hills from Newcastle University, and psychologist Ivan Brown from the Applied Psychology Unit (MRC Cognition and Brain Sciences Unit) in Cambridge; variable-message signs (VMS) on the M6; before joining the M25, the vehicles had an average speed of 50 mph; the early plans in the 1940s for the M25, which the M25 to the south and west of London, now largely follows; when the M25 needed to be built, in the 1960s, many environmental objections had arisen for it to be built; Russ Kane in Capital Radio's Flying Eye; David Marsh at the AA Roadwatch studio in north London; the ramp meter, installed on the M6 by John Wootten; all of London's traffic lights were controlled from a computer centre in Westminster, with software (Split Cycle Offset Optimisation Technique) developed by Dennis Robertson; the Volvo 850 enters London along the Edgware Road and Park Lane to Hyde Park Corner; the prototype Autoguide system invented by Ian Catling; automatic vehicle identification (AVI) and piezoelectric strips developed at the University of Nottingham Department of Civil Engineering, and tested by Peter Davies on the Nottingham ring road, next to the QMC; the Volkswagen Passat arrives first at the Great Danes Hotel, making the 107 miles in two hours seventeen minutes, an average speed of 47 mph; the route south of London - 119 miles, also has a 47 mph average speed; the 96-mile rail journey had an average speed of 35 mph; the programme content would be copied by Top Gear fifteen years later. Narrated by Martin Jarvis, produced by David Sharp, directed by Mike Tomlinson, made by Orlando Productions 9 October Look, No Hands! about technology outpacing human knowledge; Hubert Dreyfus of University of California, Berkeley; Martin Corbett, industrial psychologist at the University of Warwick; work by Mike Cooley, and systems design; mechanical engineer Frederick Winslow Taylor and his meticulous improvements to industrial methods, in his book The Principles of Scientific Management; John Harris, manager of the Rolls-Royce helicopter engine plant at Leavesden, Hertfordshire; perhaps automation in engineering manufacturing processes could perhaps add or enhance, rather than totally replace, which required and produced less directly competent workers. Produced by Debra Hauer, directed by Christopher Rawlence, made by Hauer Rawlence Productions 16 October Spytech, John Pike of the Federation of American Scientists and how the Space Shuttle was built mostly for low Earth orbit reconnaissance satellites; but the Titan 34D was also available for many spy satellite launches; Christopher Andrew of the University of Cambridge; Harry Rositzke of the CIA, and the disastrous Operation Red Sox, from 1949 to 1953; William Colby, Director from 1973 to 1976 of the CIA, and how spying methods that worked in Germany during World War II were simply hopeless in a possibly more bizarre culture of communist eastern Europe in the early 1950s, so Ferret missions by B-29 aircraft over the border were attempted instead, but many were shot down; the Americans decided to go for high-altitude reconnaissance; on 1 May 1960, an aircraft photographing a missile construction factory, pilot was sentenced to 10 years, but released after two years in exchange for Rudolf Abel; H. Keith Melton and notorious improvised technology of the KGB; the Russian defector Stanislav Levchenko; the burst transmission method; camera lenses for spy satellites made by Itek; the Space Shuttle was built to maintain and repair the Key Hole set of spy satellites, such as KH-11 KENNEN, launched by the National Reconnaissance Office (NRO) in 1976, and introduced digital photography, and EOSAT and its Landsat program; Jeffrey T. Richelson, a writer on national security; Major-General George Keegan of the Twenty-Fifth Air Force described how the Soviet Union got to know when spy satellites would be overhead, and would hide anything sensitive; listening satellites sent their data to the NSA at Fort Meade in Maryland, such as data from Magnum, launched by the secret STS-51-C mission in January 1985; Paul Bracken and all-source intelligence fusion; Soviet intelligence in the US was quite widespread, with up to 800 spies operating out of Soviet trade missions, and operated much more widespread than the US had attempted; the new KH-12 satellite, that launched in November 1992, could see through clouds. Narrated by Mike Short, produced by Claudia Milne, made by Twenty Twenty 23 October Bamboo, the importance of bamboo to the Chinese economy; Prof Hsiung Wenyue of the Bamboo Research Centre of Nanjing Forestry University; bamboo structures do not collapse in high winds; over a thousand species of bamboo; bamboo dies out for ten years, then grows again; only 15% of China can be cultivated; bamboo can grow four feet in 24 hours, it is the fastest growing plant; bamboo has a tensile strength twice as much as timber; hospitals in China worked with herbal remedies; bamboo traders had quotas set by the Chinese government; bamboo shoots were mostly exported to Japan; growing bamboo helped soil structure; the Chinese government encouraged the growing of bamboo, as an alternative to timber. Narrated by Jenny Agutter, produced by Michael Blakstad, directed by Patrick Fleming, made by Workhouse Productions, made in cooperation with China Central Television 30 October Heavy Metal, chemist Neil Ward of the University of Surrey, who found abnormal pregnancies; medical doctor Robin Russell-Jones of the Campaign for Lead Free Air; environmental chemist Brian Davies of the University of Bradford; footage from the 1971 BBC A Public Poison, with chemist Derek Bryce-Smith, and Patrick Lawther of St Bartholomew's Hospital; Gloria all'Egitto from Aida by Giuseppe Verdi, with the assembly line of the Rover 800; Robin Brundle; Eric Fountain of Vauxhall Motors; Ojos Criollos by Louis Moreau Gottschalk. Narrated by Catherine Robins, produced by Michael Blakstad, made by Workhouse Productions 13 November Free Flight, about gliding, with Derek Piggott in a Rolladen-Schneider LS4 at Booker Gliding Centre in Buckinghamshire; in the UK there were about 350,000 flights and 2 deaths each year; a Schleicher ASW 24 in a wind tunnel with Loek Boermans at TU Delft Faculty of Aerospace Engineering in the Netherlands; the Schleicher ASH 25 with glider pilot John Jeffries at London Gliding Club west of Dunstable; at Wasserkuppe, a 3,000 ft mountain in the east of Hesse in the centre of Germany is where gliding mostly developed in the 1920s by the Deutsche Forschungsanstalt für Segelflug, due to German powered-aircraft manufacturing being legally restricted; nearby at Poppenhausen, Hesse is Alexander Schleicher GmbH & Co, with designer Gerhard Waibel, where gliders had wings made from carbon fibre, and covered in kevlar for torsional stiffness; the first glider of a contemporary design was the Akaflieg Stuttgart fs24 in 1951. Narrated by Robert Gary 20 November Chaos, Tim Palmer of the ECMWF; mathematician Robert L. Devaney; German mathematician Heinz-Otto Peitgen and fractal geometry; strange attractors in dynamical systems, such as weather systems; David Rand of the University of Warwick, and period-doubling bifurcation, discovered in 1975 by mathematician Mitchell Feigenbaum discovered; fractal landscapes; British mathematician Michael Barnsley, and affine transformations, which are applied to digital image processing; the chaos game; Soviet physicist Lev Landau; physicist Harry Swinney of the University of Texas; economist James B. Ramsey; Ian Stewart of the University of Warwick, and the unpredictable rotation of Hyperion. Written, produced and directed by Chris Haws, the programme was made by Independent Communications Associates (InCA). In 1989, it won the SciTech Award for best scientific documentary. 27 November The Art of Deception, about camouflage, deception, decoys and stealth. The Northrop Grumman B-2 Spirit was first displayed on Tuesday 22 November 1988, just five days before the programme was aired. Featured interviewees include: Richard P. Hallion of Wright-Patterson Air Force Base; Peter Varnish of the Admiralty Research Establishment at Funtington in West Sussex; defence writer Antony Preston; Roy Behrens of the Art Academy of Cincinnati; Lt Col Chris Nash of Surveillance, Target Acquisition, Night Observation and Counter-surveillance (STANOC); Major William Marshak of the AAMRL - now the 711th Human Performance Wing; Captain Brian Perowne, commanding officer of HMS Brazen (F91); aviation writer Bill Sweetman, and Commander Patrick Walker, commanding officer of HMS Trafalgar (S107) a Royal Navy hunter-killer submarine; John Hall of the Admiralty Research Establishment (former Admiralty Experiment Works) at Haslar. Narrated by Nick Chilvers, Written, produced and directed by Chris Haws, made by InCA and WGBH Boston
Sources: en.wikipedia.org
Dòugān (豆乾, literally "dry tofu" in Chinese) is an extra firm variety of tofu where a large proportion of the liquid has been pressed out. Dòugān contains the least moisture of all fresh tofu, the firmness of fully cooked meat, and a somewhat rubbery feel similar to that of paneer. It is not easily crumbled except when sliced thinly. Some varieties of dougan has the pattern of the muslin used to drain and press it. Western firm tofu is milled and reformed after pressing. One way to cook dougan is to cut it into thin slices called shredded dried tofu (乾絲, gānsī). The strings look like loose cooked noodles and can be served cold, stir-fried, or added to soup, as with Japanese aburaage.
== Function == This gene is a member of the NAD(P)H dehydrogenase (quinone) family and encodes a cytoplasmic 2-electron reductase. This FAD-binding protein forms homodimers and reduces quinones to hydroquinones. This enzyme facilitates the two electron reduction of quinone to hydroquinone. NQO1-mediated two electron reduction of quinone to hydroquinone thereby indirectly prevents the one electron reduction of quinone to the semiquinone free radical. The ubiquitin-independent p53 degradation pathway is regulated by NQO1. NQO1 stabilizes p53, protecting it from degradation. Individuals with decreased NQO1 expression/activity have reduced p53 stability, which may lead to resistance to drugs such as chemotherapeutics.
4-Hydroxytryptamine (4-HT, 4-HTA), also known as N,N-didesmethylpsilocin, is a naturally occurring tryptamine alkaloid. It is closely related chemically to the neurotransmitter serotonin, the psychedelic psilocin, and is the active form of the tryptamine alkaloid norbaeocystin. The compound is a serotonin receptor agonist, including of the serotonin 5-HT2A receptor, but in contrast to certain closely related compounds like psilocin, appears to be non-hallucinogenic. 4-HT may occur naturally in Psilocybe baeocystis and Psilocybe cyanescens. It may serve as an alternative precursor in the biosynthesis of psilocybin (4-PO-DMT) in psilocybin mushrooms.
=== Editing and producing === Phang has also edited and produced the feature film Target Audience 9.1 (2007), written and directed by Dominic Mah, produced the short film Sitter (2004) also written and directed by Dominic Mah, and served as executive producer for the short film Crazy Beats Strong Every Time (2011), directed and written by Moon Molson, and which was an official selection of the 2011 Sundance Film Festival. Phang also shares an editing credit on her 2015 feature Advantageous. Phang works closely with Premiere Pro and uses After Effects when dealing with VFX.
Sources: en.wikipedia.org
ACC synthase reaches optimal activity in conditions of pH 8.5 and with Km = 20 um relative to its substrate, SAM. ACC Synthase and ethylene biosynthesis are regulated by a whole host of stimuli. Stresses such as wounding, noxious chemicals, auxin, flooding, and indole-3-acetic acid (IAA) promote ethylene synthesis, creating a positive feedback cycle with ACC synthase, up-regulating its activity. However, it is also inhibited by a number of compounds as well. S-Adenosylethionine can bind as a substrate for ACC synthase (with higher affinity than SAM) and therefore inhibit any reaction with SAM. ACC Synthase is also competitively inhibited by aminoethoxyvinylglycine (AVG) and aminooxyacetic acid (AOA), inhibitors to many pyridoxal phosphate-mediated enzymic reactions. They are natural toxins that cause slow binding inhibition by interfering with the coenzyme pyridoxal phosphate. ACC synthase activity is also inhibited by intermediates of the activated methyl cycle and the methionine-recycling pathway: 5′-methylthioadenosine, α-keto-γ-methylthiobutyric acid, and S-adenosylhomocysteine.
The third major group of regulatory RNAs is called enhancer RNAs. It is not clear at present whether they are a unique category of RNAs of various lengths or constitute a distinct subset of lncRNAs. In any case, they are transcribed from enhancers, which are known regulatory sites in the DNA near genes they regulate. They up-regulate the transcription of the gene(s) under control of the enhancer from which they are transcribed.
The reported abundance of bismuth in the Earth's crust varies significantly by source from 180 ppb (similar to that of silver) to 8 ppb (twice as common as gold). The most important ores of bismuth are bismuthinite and bismite. Native bismuth is known from Australia, Bolivia, and China.
Another meta analysis of 4 trials with follow-up longer than 1 year found similar results. Nissen's meta analysis was criticized in a 2007 article by George Diamond et al. in the Annals of Internal Medicine. The authors concluded that Nissens' analysis had excluded trials with important data on the cardiovascular profile of rosiglitazone, had inappropriately combined trials of greatly differing design, and had inappropriately excluded trials with no cardiovascular events. The authors concluded that no firm conclusion could be drawn regarding whether rosiglitazone increased or decreased cardiovascular risk. Investigators from the Cochrane Collaboration published a meta-analysis of their own on the use of rosiglitazone in Type II diabetes, concluding there was not sufficient evidence to show any health benefit for rosiglitazone. Noting the recent publication by Nissen, they repeated their meta analysis including only the trials included in the Nissen study that dealt with Type II diabetics. (The Nissen study included some trials in people with other disorders.) They did not find a statistically significant increase in cardiovascular events, but noted that all of the cardiovascular endpoints they analyzed showed a non-significant trend toward worse outcomes in the rosiglitazone arms. In July 2007 the FDA held a joint meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee. FDA scientist Joy Mele presented a meta analysis examining the cardiovascular risk of rosiglitazone in completed clinical trials.
Since the bacteriophage Phage Φ-X174 was sequenced in 1977, the DNA sequences of thousands of organisms have been decoded and stored in databases. This sequence information is analyzed to determine genes that encode proteins, RNA genes, regulatory sequences, structural motifs, and repetitive sequences. A comparison of genes within a species or between different species can show similarities between protein functions, or relations between species (the use of molecular systematics to construct phylogenetic trees). With the growing amount of data, it long ago became impractical to analyze DNA sequences manually. Computer programs such as BLAST are used routinely to search sequences—as of 2008, from more than 260,000 organisms, containing over 190 billion nucleotides.
Sources: en.wikipedia.org
BPC-157 is a synthetic fifteen-amino-acid peptide whose sequence corresponds to a fragment of a protein found in human gastric juice. It is studied mainly in preclinical research and is not an approved pharmaceutical product in major markets. Materials sold for laboratory use are typically labelled as research chemicals.
No medicines regulator in the United States or the European Union has approved BPC-157 as a therapeutic product. Presenting it as a drug or as a dietary supplement ingredient would generally not match its regulatory status. Availability as a research chemical does not imply clinical approval.
Published reports rest largely on animal models and cell culture rather than controlled human trials. Review articles describe the proposed mechanisms as incompletely understood. Conclusions about effects in humans therefore remain tentative.
It is not authorized as a medicine in the United States or the European Union. Regulatory treatment varies by jurisdiction, and in several places it is handled as a research chemical. Therapeutic claims are not supported by large human trials.